ProtocolProtocolsFree

BPC-157 & TB-500: The Complete Protocol

Dosing, timing, reconstitution, and stacking strategies for the most popular healing peptides. Includes injury-specific protocols and cycling recommendations.

15 min read
Share:
By Peptides.NYC Editorial TeamUpdated May 21, 2026
Educational content only — not medically reviewed. Consult a licensed healthcare provider before acting on anything here.

Educational content only. Not medical advice. The content creators are not doctors or medical professionals. Consult your healthcare provider before taking any action.

BPC-157 & TB-500: The Complete Protocol

Category: Protocols Type: Protocol Read Time: 15 minutes Author: Peptides.NYC Editorial Last Updated: 2026-04-10 URL: https://peptides.nyc/learn/bpc-157-tb-500-protocol


Overview

Dosing, timing, reconstitution, and stacking strategies for the most popular healing peptides. Includes injury-specific protocols and cycling recommendations.

Why Combine BPC-157 and TB-500?

The BPC-157 + TB-500 stack is the most popular healing peptide combination for good reason. These peptides work through complementary mechanisms to accelerate tissue repair.

Synergistic Benefits:

  • BPC-157: Local tissue healing, gut-brain axis, angiogenesis
  • TB-500: Systemic distribution, cell migration, anti-inflammatory
  • Together: Enhanced and faster recovery than either alone

Best For:

  • Stubborn injuries that won't heal
  • Tendon and ligament damage
  • Muscle tears
  • Post-surgical recovery
  • Chronic overuse injuries

The Combined Protocol

Standard Healing Stack:

BPC-157:

PhaseDoseFrequencyDuration
Treatment250-500mcgDaily4-8 weeks

TB-500:

PhaseDoseFrequencyDuration
Loading2.5mg2x weekly4 weeks
Maintenance2.0-2.5mg1x weekly4+ weeks

Combined Daily Schedule:

Morning:

  • BPC-157: 250mcg subcutaneous (near injury if applicable)

TB-500 Injection Days (2x weekly during loading):

  • TB-500: 2.5mg subcutaneous (any site)

Note: BPC-157 is daily; TB-500 is 2x weekly initially, then weekly.

Injury-Specific Protocols

Tendon Injuries (Rotator Cuff, Achilles, Elbow)

Protocol:

  • BPC-157: 500mcg daily near injury site
  • TB-500: 2.5mg 2x weekly loading, then weekly
  • Duration: 8-12 weeks

Additional Support:

  • Collagen supplementation
  • Reduced load on affected area
  • Physical therapy when able

Ligament Injuries (ACL, MCL, Ankle Sprains)

Protocol:

  • BPC-157: 500mcg daily near injury
  • TB-500: 2.5mg 2x weekly for 6 weeks
  • Duration: 8-12 weeks minimum

Notes:

  • Ligaments heal slower than muscle
  • Longer duration often needed
  • Support with appropriate rehab

Muscle Tears and Strains

Protocol:

  • BPC-157: 250-500mcg daily
  • TB-500: 2.5mg 2x weekly for 4 weeks
  • Duration: 4-6 weeks typical

Notes:

  • Muscle heals faster than tendons
  • May see results in 2-3 weeks
  • Gradual return to activity

Post-Surgical Recovery

Protocol:

  • Wait until initial wound closure
  • BPC-157: 250mcg 2x daily
  • TB-500: 2.0mg 2x weekly
  • Duration: 4-8 weeks post-surgery

Important:

  • Consult with surgeon first
  • Monitor wound healing
  • Report any concerns immediately

Gut Healing (IBS, Leaky Gut)

Protocol:

  • BPC-157: 500mcg daily (oral or injectable)
  • TB-500: Optional - 2.5mg weekly can support
  • Duration: 8-12 weeks

Additions:

  • Consider KPV for inflammation
  • Dietary modifications essential
  • Probiotics and gut support

Reconstitution Guide

BPC-157 (5mg vial):

  • Add 2ml BAC water = 2.5mg/ml
  • 0.1ml (10 units) = 250mcg
  • 0.2ml (20 units) = 500mcg

TB-500 (5mg vial):

  • Add 2ml BAC water = 2.5mg/ml
  • 1ml = 2.5mg

Reconstitution Steps:

  1. Allow vials to reach room temperature
  2. Clean vial tops with alcohol swabs
  3. Draw appropriate BAC water amount
  4. Inject slowly down side of vial
  5. Swirl gently - never shake
  6. Let dissolve completely
  7. Refrigerate immediately
  8. Label with date and concentration

Stability After Mixing:

  • BPC-157: 3-4 weeks refrigerated
  • TB-500: 2-3 weeks refrigerated
  • Never freeze after reconstitution
  • Protect from light

Injection Guidelines

BPC-157 Injection:

  • Best practice: Inject close to injury site
  • Systemic option: Abdomen subcutaneous
  • Depth: Just under skin (subcutaneous)
  • Needle: 29-31 gauge insulin syringe

TB-500 Injection:

  • Location: Any subcutaneous site (systemic anyway)
  • Common sites: Abdomen, thigh
  • Depth: Subcutaneous
  • Needle: 29-31 gauge insulin syringe

Rotation:

  • Rotate injection sites
  • Don't inject same exact spot daily
  • Prevents irritation and scar tissue

Timing and Scheduling

Sample Weekly Schedule:

DayMorningEvening
MondayBPC-157 250mcgTB-500 2.5mg
TuesdayBPC-157 250mcg-
WednesdayBPC-157 250mcg-
ThursdayBPC-157 250mcgTB-500 2.5mg
FridayBPC-157 250mcg-
SaturdayBPC-157 250mcg-
SundayBPC-157 250mcg-

Timing Considerations:

  • BPC-157: Can be taken any time, some prefer fasted
  • TB-500: No specific timing requirements
  • Consistency matters more than exact timing

Expected Results Timeline

Week 1-2:

  • Reduced inflammation
  • Less pain at injury site
  • Improved comfort

Week 3-4:

  • Noticeable healing progress
  • Better range of motion
  • Increased activity tolerance

Week 5-8:

  • Substantial recovery
  • Return of function
  • Continued strengthening

Week 8-12:

  • Full or near-full recovery for many
  • Gradual return to normal activity
  • Consider maintenance or cycling off

Cycling Recommendations

After Initial Protocol:

  • Option 1: Stop both after 8-12 weeks, reassess
  • Option 2: Continue BPC-157 daily, TB-500 weekly maintenance
  • Option 3: Cycle 4-8 weeks on, 4 weeks off, repeat if needed

Long-Term Maintenance:

For chronic or recurring issues:

  • BPC-157: 250mcg daily or every other day
  • TB-500: 2.5mg monthly

What to Track

Document throughout your protocol:

  • Pain levels (1-10 scale)
  • Range of motion
  • Function/activity capacity
  • Sleep quality
  • Any side effects
  • Injection sites and dates

Common Questions

Q: Can I mix them in the same syringe? A: Not recommended. Keep separate for stability and accurate dosing.

Q: Which is more important if I can only afford one? A: BPC-157 is often considered more versatile for localized healing. TB-500 excels at systemic support for larger injuries.

Q: Do I need to inject at the injury site? A: BPC-157 works better locally. TB-500 distributes systemically regardless of injection site.

Q: Can I take BPC-157 orally instead? A: Yes, BPC-157 has oral bioavailability, especially for gut issues. TB-500 must be injected.


Related Content


Disclaimer: This content is for educational purposes only and is not medical advice. These are research compounds not FDA-approved for human use. Consult a healthcare provider before starting any peptide protocol.

Source: https://peptides.nyc/learn/bpc-157-tb-500-protocol

Not medically reviewed

This content is produced by the Peptides.NYC editorial team from published research. It has not been reviewed by a licensed clinician and is educational only — always consult your healthcare provider before starting, stopping, or adjusting any peptide protocol.

Written By

Editorial team. We cite published research; we are not licensed clinicians and content is not medically reviewed.

Peptide researchHealth writingEvidence synthesis

This article cites peer-reviewed research and medical literature. Click any reference to view the original source.

  1. 1

    Sikiric P, Seiwerth S, et al. (2018) Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions Life Sciences.

    PMID: 29337192DOI: 10.1016/j.lfs.2018.01.023View on PubMed
  2. 2

    Sikiric P, et al. (2016) Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract Current Pharmaceutical Design.

    PMID: 27510481DOI: 10.2174/1381612822666160720150010View on PubMed
  3. 3

    Bock-Marquette I, et al. (2004) Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair Nature.

    PMID: 15269782DOI: 10.1038/nature02582View on PubMed
  4. 4

    Philp D, et al. (2007) Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development Annals of the New York Academy of Sciences.

    PMID: 17470963DOI: 10.1196/annals.1392.015View on PubMed
  5. 5

    Seiwerth S, et al. (2021) BPC 157 as potential treatment for COVID-19 Medical Hypotheses.

    PMID: 33316755DOI: 10.1016/j.mehy.2020.110329View on PubMed

Medical Disclaimer

The information on this website is for educational purposes only and is not medical advice. The content creators are not doctors or medical professionals. This content should not be used to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before starting any new supplement, medication, or health protocol. You assume all risks associated with using this information.